Reaction
Infusion Site Discolouration reporting signals
As of the last recalculation, Infusion Site Discolouration appears in 850 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is KETOPROFEN (PRR 111.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ketoprofen | 56 | 111.8 | 112.3 |
| Treprostinil | 293 | 86.7 | 86.9 |
| Amitriptyline Hydrochloride | 52 | 77.2 | 77.5 |
| Iron Sucrose | 26 | 68.9 | 69.0 |
| Human Immunoglobulin G | 42 | 52.4 | 52.5 |
| Lidocaine Hydrochloride | 91 | 41.3 | 41.3 |
| Macitentan | 92 | 36.4 | 36.4 |
| Sildenafil Powder, | 48 | 34.9 | 35.0 |
| Sildenafil | 73 | 33.7 | 33.7 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 25 | 29.5 | 29.5 |
| 0Xygen | 55 | 29.2 | 29.2 |
| Oxygen | 55 | 29.2 | 29.2 |
| Sodium Chloride Tablet | 79 | 28.9 | 28.9 |
| Sodium Chloride Tablets | 79 | 28.9 | 28.9 |
| Clonidine | 55 | 28.0 | 28.1 |
| Sodium Chloride | 79 | 26.9 | 26.9 |
| Adrenalinum | 42 | 26.0 | 26.0 |
| Tadalafil | 84 | 22.7 | 22.7 |
| Diphenhydramine | 54 | 22.3 | 22.3 |
| Sildenafil Citrate | 98 | 21.2 | 21.2 |
| Lidicaine | 39 | 20.4 | 20.4 |
| Burn Relief | 39 | 20.4 | 20.4 |
| Lidocaine Hydrochloride And Epinephrine | 39 | 20.4 | 20.4 |
| Lidocaine, Menthol | 39 | 20.1 | 20.1 |
| Epinephrine | 50 | 19.8 | 19.8 |
| Lidocaine | 43 | 19.0 | 19.0 |
| Riociguat | 23 | 17.7 | 17.7 |
| Selexipag | 18 | 17.4 | 17.4 |
| Ambrisentan | 78 | 16.7 | 16.8 |
| Buspirone Hydrochloride | 7 | 15.7 | 15.7 |
| Azelastine | 11 | 15.2 | 15.2 |
| Bendamustine Hydrochloride | 6 | 12.3 | 12.4 |
| Bosentan | 20 | 9.9 | 9.9 |